Pharmaceutical manufacturers are padding their wallets while rural families and retirees are squeezed by a system designed to benefit shareholders, not patients,” writes Tonja Hanson in an op-ed.

The Trump administration is experiencing some cognitive dissonance: The new president’s Justice Department is going to bat ...

Hospital Authority official says the aim of adjusting fees is not to save costs but to boost resources for patients with ...

Pharmaceuticals announced updated clinical data from Part 1b of the ongoing DENALI clinical trial of azenosertib in patients ...

On St Patrick's Day, investors hope for the luck of the Irish ahead of Opthea's key trial update and Imricor's ambitious fund ...